Bonumose – a Virginia-based startup with patented technology it claims could enable the mass market adoption of rare sugars which have exciting benefits but currently come with a hefty price tag – is gearing up to start commercial production of tagatose...
The FDA has denied a request to exempt rare sugar tagatose from the total and added sugars declaration on the Nutrition Facts panel, three years after granting the same request for rare sugar allulose, a decision petitioner Bonumose has slammed as “contradictory...
Bonumose – a Virginia-based startup with patented technology it claims could enable the mass market adoption of rare sugars such as allulose and tagatose – is investing $27.7m in production and R&D facilities in a 36,000 sq ft facility in Pantops,...
While it has the same number of calories per gram as regular sugar, the tooth-friendly ‘slow-carb’ isomaltulose is metabolized very differently to sucrose, and like allulose, should not have to count towards grams of total or added sugar on food labels,...
Leading CPG companies including Unilever, Hershey, and General Mills have urged the FDA to look again at the way some sugars such as tagatose and isomaltulose are labeled on the Nutrition Facts panel in the wake of recent changes to the way allulose is...
From San Diego-based Debut Biotech, which is developing a range of high-value ingredients via a novel ‘cell-free’ biomanufacturing platform, to Virginia-based Bonumose, which has patented technology it claims could enable the “mass market adoption” of...
With demand for rare sugar allulose currently exceeding supply, Tate & Lyle has informed some partners that it is withholding supplies of the sweetener until further notice, FoodNavigator-USA understands.
Bonumose – a Virginia-based startup with patented technology it claims could enable the “mass market adoption” of rare sugars – has raised a Series B* round led by Hershey and sugar refining giant ASR Group, to support commercial production of allulose...